US-based global provider of enterprise image management systems, Mach7 Technologies has completed the $60m merger with 3D Medical, a provider of 3D printing.

Approved by shareholders of both firms last month, 3D Medical will act as a wholly-owned subsidiary of Mach7, who will trade on the Australian Stock Exchange under the symbol M7T and will henceforth be known as Mach7 Technologies.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The merger is said to provide customers across five continents access to advanced medical image management solutions.

"The merger is said to provide customers across five continents access to advanced medical image management solutions."

The newly merged Mach7 Technologies will offer enterprise imaging solutions to unlock patient data, to leverage on care intelligence and for shift management, sharing and use of medical imaging for powering the healthcare ecosystem, according to a report by 3dprint.com.

Mach7 managing director and CEO Albert Liong said: "Our commitment to customer-driven design remains the core of our culture and the soul of our business philosophy.

"We are a company born of innovation and growing through extraordinary collaboration to bring advanced enterprise data management and medical solutions to our expanding network of customers, healthcare communities and globally connected healthcare ecosystems."

The merger will allow Mach7 to tap into the international capital markets while preserving corporate self-determination for both entities in both mission and product roadmap.

Both the merged companies will retain their portfolio of workforces in the field of engineering, customer sales, support, marketing, and service relationships.

Mach7 will maintain its Burlington, Vermont headquarters for product development, professional services, sales and marketing, with expanded sales throughout Australia, New Zealand and Western Europe.

Albert Liong was appointed as the managing director and CEO, Jenni Pilcher assumed the role of the global CFO and CEO of Australia operations and Ken Poutakidis was appointed as the non-executive chairman.